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This study was carried out to evaluate the protective eﬀect of anthocyanins extract of blueberry on trinitrobenzene sulfonic acid
(TNBS)-induced inﬂammatory bowel disease (IBD) model of mice. The study employed female C57BL/6 mice (n = 50), and
colitis was induced by intracolonic injection of 0.5mg of TNBS dissolved in 50% ethanol–phosphate buﬀered solution. The
mice were divided into ﬁve groups (n = 10): vehicle, TNBS control and anthocyanins groups that received diﬀerent doses of
anthocyaninsextract(10,20and40mgkg−1)dailyfor6days.Bothincreaseinbodyweightanddiarrheasymptomsweremonitored
each day. After 6 days, the animals were killed, and the following parameters were assessed: colon length, morphological score,
histological score and biochemical assay (NO, myeloperoxidase (MPO), interleukin (IL)-12, IL-10, tumor necrosis factor (TNF)-
α and interferon (IFN)-γ). The results showed that the anthocyanins extract of blueberry rendered strong protection against
TNBS-induced colonic damage at a dosage of 40mgkg−1. When compared with the control, anthocyanins extract signiﬁcantly
prevented loss of body weight and ameliorated the scores of diarrhea, morphology and histology. Treatment with anthocyanins
extract restored IL-10 excretion, as well as caused reduction in the levels of NO, MPO, IL-12, TNF-α and IFN-γ. Our research
revealed the protective eﬀect of anthocyanins extract from blueberry on TNBS-induced experimental colitis in mice, as well as
examined whether high levels of dietary blueberries would lower the risk or have protective eﬀects on human IBD, which may
require further investigation.
1.Introduction
Blueberries are among the fruits that are best recognized
for their potential health beneﬁts [1], and many of the
heath-promoting properties of blueberries are thought to be
attributable to anthocyanins that structurally belong to the
natural products of ﬂavonoids (Figure 1). Anthocyanins are
water-soluble pigments that might appear as red, purple or
blue pigments according to their pH levels and are present in
blueberries at high concentrations [2]. Anthocyanins from
blueberries are also used as anti-inﬂammatory, antimuta-
genicandrhodophylacticagents,andtheprincipaltherapeu-
tic beneﬁts attributable to anthocyanins include antioxidant
protection and maintenance of DNA integrity [3, 4].
Inﬂammatoryboweldisease(IBD)isachronic,relapsing,
idiopathicinﬂammationofthegastrointestinaltract.Patients
suﬀering from IBD experience a set of gastrointestinal
symptoms, and their quality of life is also limited by some
complications such as: toxic megacolon [5], bowel perfo-
ration [6] and surgical complications [7]. It often leads
to long-term and sometimes irreversible impairment of
gastrointestinal structure and function. Besides deteriorated
living quality, IBD patients also have higher risk of colon
cancer [8]. IBD has exhibited high prevalence in developed
Western countries; however, in Asia, its prevalence is much
lower [9]. Some believe that Oriental diet enriched with
diﬀerent kinds of ﬂavonoids might be one of the most
important factors rendering resistance to colon disease.
Furthermore, some studies have revealed that anthocyanins
have protective eﬀect against colon cancer in rats [10]. As
various evidences have demonstrated that there is a close
interconnection between colitis and colon cancer, it was
worth investigating the protective eﬀect of anthocyanins on
colitis, based on these aspects.
In this study, we reconstructed the trinitrobenzene
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Figure 1: General structure of anthocyanidins (aglycons).
monitored for diarrhea, the resulting loss of body weight and
animal death every day in the whole experimental course.
Subsequently, we investigated the function of neutrophilic
granulocyte using myeloperoxidase (MPO) assay; in addi-
tion, the severity of colitis was also assessed by both macro-
scopical and histological detection. Finally, we detected the
inﬂuence of anthocyanins on the production of interleukin
(IL)-10 and -12, NO, tumor necrosis factor (TNF)-α and
interferon (IFN)-γ in the tissues. Thus, evaluation of the
protective eﬀect of anthocyanins extract of blueberry on IBD
might shed light on drug discovery or alternative therapy for
IBD treatment.
2. Methods
2.1. Animals and Grouping. Female C57BL/6 mice were pur-
chased from Experimental Animal Center of Harbin Medical
University. The animals, 8–12 weeks of age, weighing 18–
22g, were kept under speciﬁc pathogen-free environment.
They were maintained in plastic cages with free access to pel-
let food and water, at 21 ± 2◦C and kept on a 12-h light/dark
cycle. Animal welfare and experimental procedures were
carried out strictly in accordance with the guidance for
care and use of laboratory animals (National Research
Council of USA, 1996) and the related ethical regulations
of our university. All eﬀorts were made to minimize the
animal’s suﬀering and to reduce the number of animals
used. The mice were randomly divided into ﬁve groups,
each containing 10 mice: vehicle group received 100μLo f
50% ethanol-phosphate buﬀered solution (PBS) by rectal
needle; control group received a single rectum injection of
0.5mg of TNBS only; and experimental IBD mice received
anthocyanins extract at doses of 10, 20 and 40mgkg−1.T h e
anthocyanins groups were orally administered with diﬀerent
doses of anthocyanins dissolved in 100μLo fp h y s i o l o g i c a l
saline once every day, and the vehicle and control groups
were also administered with equal volume of physiological
saline daily.
2.2. Therapeutic Agents and Reagents. Anthocyanins extract
preparation: ripe blueberries (Vaccinium ashei) picked from
the ﬁeld were freeze-dried and then powdered. The powder
was kept at −70◦ until further use. The freeze-dried powder
was extracted using methanol/water/acetic acid (85:15:0.5,
v/v, MeOH/H2O/AcOH) thrice as previously reported, and
the anthocyanins content of the extract was about 32%,
which was observed using UV-Vis spectra analysis [11, 12].
Subsequently, the solution was ﬁltered and concentrated
in vacuum under 40◦C. The residue was lyophilized and
kept at −70◦C; TNBS (Sigma, St Louis, MO, USA), Nitric
Oxide Assay Kit (Beyotime, Shanghai, China), MPO Assay
Kit (Beyotime, Shanghai, USA), TNF-α,I F N - γ,I L - 1 0a n d
-12 and ELISA Kit (R&D system, MN, USA) were used for
the study.
2.3. Induction of TNBS Colitis. Colitis was induced by a
single intracolonic injection of 0.5mg of TNBS dissolved
in 50% ethanol-PBS solution into the descending colon.
The volume of TNBS enema was kept at 100μL. The mice
were placed under low dosage of ether anesthesia; later, a
rubber catheter lubricated with cosmolin was inserted into
the colon through anus. TNBS was injected only when the
tipofthecatheterwas4cminsidefromtheanus.Theanimals
were observed for 6 days, and afterwards, killed under ether
anesthesia by cervical dislocation, for the assessment of
various parameters.
2.4. Assessment of TNBS Colitis. The increase in body
weight, diarrhea score and mortality rate of the animals
was monitored daily. Diarrhea was scored as follows: 0,
normal; 2, loose previous term stools; and 4, diarrhea. After
6 days, the mice were killed, and colons were collected
and evaluated for colon length and macroscopic score. The
score of macroscopy was given based on the following
criteria: 0, normal; 1, erythema only; 2, erythema, slight
edema and small erosions; 3, two or more bleeding ulcers
and/or inﬂammation and/or moderate adhesions; and 4,
severe ulceration and/or stenosis with dilations and/or severe
adhesions.Wealsocollectedthesampleofcolon,andpartsof
them were stored at −70◦Cf o rp r o t e i ne x t r a c t i o na n dw e r e
ﬁxed in formalin for histological assay.
2.5. Histological Score of Colitis. Fixed tissue was stained
with hematoxylin and eosin for subsequent histological
examination. We gave the macroscopic score according
to the following criteria: 0, no signs of inﬂammation; 1,
low level of leukocyte inﬁltration; 2, moderate level of
leukocyte inﬁltration; 3, high level of leukocyte inﬁltration,
high vascular density and thickening of bowel wall; and 4,
transmural inﬁltrations, loss of goblet cells, high vascular
density and strong bowel wall thickening.
2.6. MPO Activity Measurement. Colonic tissues from all
the surviving mice of each group were partitioned and
stored immediately at −70◦C until further use. In all the
measurement of diﬀerent indicators, such as MPO activity,
NO release and ELISA for cytokines, the data indicated the
average value of samples from every surviving mouse in each
group. All the experiments were performed within 1 week of
collectionoftissues.TheMPOactivitywasmeasuredaccord-









































































Figure 2: (a) Eﬀects of anthocyanins extract on body weight in mice with TNBS-induced colitis. TNBS-induced colitis resulted in the loss of
animal body weight, and the body weight varied during the administration of diﬀerent doses (10, 20 and 40mgkg−1) of anthocyanins, TNBS
or vehicle in 6 days. The data were expressed as mean ± SEM. P-values were calculated using repeated measures ANOVA. A, diﬀerences
between the groups; B, diﬀerences over time; and AB, diﬀerences between the interaction of experiment and time. Pairwise comparisons
between the groups at individual time points were conducted by ANOVA and LSD post hoc test. On Days 1, 2 and 3, all pairwise comparisons
between the groups had signiﬁcant diﬀerences, except 10 and 20mgkg−1 groups (P < .001). On Days 4, 5 and 6, all pairwise comparisons
betweenthegroupshadsigniﬁcantdiﬀerences(P < .001).(b)EﬀectsofanthocyaninsextractonthesurvivalrateinmicewithTNBS-induced
colitis. TNBS-induced colitis resulted in animal death in the whole experiment course when compared with the TNBS-group mice that were
given 20 and 40mgkg−1 anthocyanins extract, which showed much less mortality rate.
The tissues were homogenized in hexadecyltrimethylammo-
nium bromide in 50mM of potassium phosphate buﬀer.
Aliquots were then added to O-dianisidine hydrochloride
solution. The absorbance was read at 450nm using a
microplatereader.MPOwasexpressedinunitspermilligram
of tissue, where 1U corresponded to the activity required to
d e g r a d e1m m o lo fh y d r o g e np e r o x i d ei n1m i na t2 4 ◦C.
2.7. NO Release Measurement. The kit principle was based
on Greiss reagent. The tissues were smashed after incubation
in liquid nitrogen and suspended in suspending buﬀer
(NaCl 0.1molL−1, Tris–HCl 0.01molL−1,p H7 . 6 ,e g t a z i c
acid 1mmolL−1, aprotinin 1mgL−1 and PMSF 100mgL−1).
After centrifugation, 50μL of Griess reagent (equal volume
of 1% sulfanilamide in HCl of 0.1molL−1 and 0.1% N-(-
1-naphthyl-ethylenediamine dihydrochloride)) was added to
50μL of the suspending media. Nitrite concentration was
determinedbyspectrophotometry(560nm)fromastandard
curve (0–100mmolL−1)d e r i v e df r o mN a N O 2 (Beyotime
Biotechnology). The NO data were expressed as mean
(nitrite) in μmolmg−1 tissue.
2.8. ELISA for IL-12 and -10, TNF-α and IFN-γ. The levels
of IL-12 and -10, TNF-α and IFN-γ were measured using
ELISA kit [13]. Mice colonic tissues of each group were


































Figure 3: Eﬀects of anthocyanins extract on mice diarrhea score
in TNBS-induced colitis in mice. The main symptom of colitis was
diarrhea; serious diarrhea symptoms occurred in TNBS group and
did not cease until the experiment was terminated; administration
of anthocyanins extract signiﬁcantly reduced the diarrhea score in
thewholeexperimentcourse.Thescoresweregivenaccordingtothe
criteria presented in the method; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 005



















































































Figure 4: (a–c) Eﬀects of anthocyanins extract on colon length and macroscopic score in mice with TNBS-induced colitis. The colon length
of the surviving mice from each group was measured and typical sample was ﬁlmed, and the inﬂammatory severity of colon was scored.
Both these indicators were ameliorated by anthocyanins extract. The scores were given according to the criteria presented in the method.
∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 005 versus TNBS group.
10% (w/v). The plates were read at 490nm right after the
chromogenic reaction stopped.
2.9. Statistical analysis. The data were expressed as mean ±
SEM.RepeatedmeasuresANOVAtestwasusedtoanalyzethe
diﬀerences in the body weight gain between the groups, and
otherparameterdiﬀerencesbetweenthegroupswereinitially
analyzed using Student’s t-test. The level of signiﬁcance was
set at P < .05. All the analyses were performed using SPSS
12.0 software.
3. Results
3.1. Mortality and Animal Body Weight. The body weight
gain of each mouse was determined every day by comparing
the current weight with the weight on Day 0, and the
animal mortality was also observed. As shown in Figure 2(a),
when compared with the vehicle group, the body weight of
the TNBS-treated mice decreased; however, when compared
with the control, the body weight of mice administered with
40mgkg−1 of anthocyanins extract had signiﬁcant recovery.
As shown in Figure 2(b), at the end of the experiment, the
number of dead mice were 0 (0/10), 7 (7/10), 6 (6/10), 5
(5/10) and 3 (3/10) for vehicle, TNBS control, and mice
treated with anthocyanins extract of 10, 20, and 40mgkg−1,
respectively. It is clear that the mortality rate of mice
that were given high dosage of anthocyanins extract was
lesser.
3.2. Diarrhea Scoring. During the entire experiment, mice
stool consistency was monitored every day. As shown
in Figure 3, simple TNBS injection signiﬁcantly increased
the diarrhea score of the control; however, all doses of
anthocyanins extract were found to inhibit the score, which
that increased in a dose-dependent manner (P < .01).
Furthermore, anthocyanins extract was observed to relieve
the diarrhea symptom induced by TNBS.
3.3. Colon Length Change and Macroscopic Score. Figure 4(a)


































Figure 5: Results of anthocyanins extract on histological analysis in mice with TNBS-induced colitis. Slices were inspected by a certiﬁed
pathologist, and the inﬂammatory severity of colonic tissues from survived mice in each group was scored and ﬁlmed. As shown (a and b),
samples from mice that were given anthocyanins extract exhibited minor inﬂammatory reaction when compared with the TNBS group. The
scores were given according to the criteria presented in the method; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 005 versus TNBS group.
anthocyanins extract; the samples in the ﬁgure are the
representativecolonsofeachgroup.AsshowninFigure 4(b),
administration of high dose of anthocyanins extract sig-
niﬁcantly reversed the shortening of the colons owing to
inﬂammation and hydropsia of mice colons induced by
TNBS injection, and this result also had high coincidence
with the macroscopic score presented in Figure 4(c).
3.4.HistologicalAnalysis. ThecolonsofthemicewithTNBS-
induced colitis showed evidence of mucosal congestion,
erosion, loss of goblet cells, thickening of the colon wall
and high level of leukocyte and polymorphonuclear (PMN)
inﬁltration,whileweobservedimprovementintheprognosis
of the disease in groups treated with anthocyanins extract.
Figure 5(a) presents the representative photos of our section
preparations,andFigure 5(b)illustratestheaveragehistolog-
ical score.
3.5. MPO Activity Measurement. The MPO activity was used
as an index of PMN inﬁltration. The MPO activity of vehicle,
control and diﬀerent doses of anthocyanins extract is shown
in Figure 6. Mice from the control group demonstrated
the highest MPO activity in colon, while 40mgkg−1 of
anthocyanins extract signiﬁcantly inhibited the increase in
MPO activity (P < .01), and mice treated with 20mgkg−1
of anthocyanins extract showed less MPO activity (P < .05).
3.6. NO Release Measurement. IBD and animal models of
colitis were characterized by high levels of NO generation.
As anthocyanins extract might act as a therapeutic agent for6 Evidence-Based Complementary and Alternative Medicine


































induced colitis in mice. Anthocyanins extract could signiﬁcantly
reduce the increased MPO activity in colon tissue induced by
colitis. The data signify the average value of the tissues from all the
surviving mice of each group, and the sample numbers of animal
in each group were: 10, 3, 4, 5 and 7 for vehicle, TNBS control and
mice treated with anthocyanins extract of 10, 20 and 40mgkg−1,
respectively; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 005 versus TNBS group.

































Figure 7: Eﬀects of anthocyanins extract on the release of NO in
TNBS-induced colitis in mice. All doses of anthocyanins extract
signiﬁcantly inhibited NO release in mice colon tissue; ∗P<. 05,
∗∗P<. 01, ∗∗∗P<. 005 versus TNBS group.
IBD through inhibition of NO production, we investigated
the eﬀects of anthocyanins extract in down-regulating the
NO level in mice colon tissue. As shown in Figure 7,g r o u p s
administered with 10 and 40mgkg−1 anthocyanins extract
signiﬁcantly inhibited NO release induced by inﬂammation
(P < .01). In addition, 20mgkg−1 of anthocyanins extract
was also observed to reduce NO release (P < .05), but the
decrease was not in a dose-dependent manner.
3.7. Regulation of the Production of Both Pro-Inﬂammatory
and Inhibitive Cytokines. As shown in Figure 8, all doses of
anthocyanins extract from blueberries signiﬁcantly reversed
the increase in IL-12, TNF-α and IFN-γ levels, which were all
high in TNBS control, and the production of IL-10 was up-
regulated, which was inhibited in TNBS-induced colitis in
mice. The disturbances in the production of these four main
cytokines that play vital roles in the disease were balanced by
anthocyanins extract in a dose-dependent manner.
4. Discussion
Although the etiology of IBD is still unclear, it is believed
that altered immunological functions, resulting from the
interplay between genetic susceptibility and certain environ-
mental factors, can contribute signiﬁcantly to the mucosal
inﬂammation of the gastrointestinal tract. Moreover, it
is often observed to lead to long-term and sometimes
irreversible impairment of gastrointestinal structure and
function [14]. When compared with the normal physio-
logical situation, the abnormal pathological expressions of
many pro-inﬂammatory cytokines, including TNF-α,I L - 1 β
and -12, have been observed in IBD process. Nevertheless,
the imbalance in the level of pro-inﬂammatory cytokines
is involved in the maintenance of inﬂammatory response.
In the animal model, intrarectal injection of TNBS is a
well-characterized model of experimental colitis, which is
comparable with the inﬂammatory processes present in IBD,
and could demonstrate several important principles that
are relevant to IBD. In this study, we used the TNBS-
induced colitis model of mice to investigate the possible
protective eﬀect of anthocyanins extract on IBD. Another
aim of the present study was to investigate some underlying
mechanisms of the beneﬁcial eﬀects of anthocyanins extract
from blueberries on experimental colitis in mice.
First, we found that anthocyanins extract from blueber-
ries could directly improve the colitis symptoms in mice;
all doses of anthocyanins extract prevented diarrhea as well
as the resulting loss of body weight and mortality of the
experimental mice. To further elucidate this protective eﬀect,
we investigated the eﬀect of anthocyanins extract on colon
lesion. It is well known that inﬂammation of colon could
result in edema of large intestine, thus decreasing the length
ofthewholecolon.Inourexperiment,thelengthofthecolon
from TNBS experimental mice reduced by ∼15–20% than
that of the vehicle group. However, colons from mice that
were administered with anthocyanins extract were longer
than those from the TNBS group. Histological and macro-
scopic data conﬁrmed the result that oral administration
of anthocyanins extract from blueberries can alleviate the
inﬂammationofthebowel.Alltheseresultsdemonstratethat
anthocyanins extract from blueberries have protective eﬀect
on TNBS-induced colitis in mice.
Furthermore,anthocyaninsareknowntohavevitalphys-
iologicalfunctionsinplantsowingtotheirantioxidanteﬀect;
MPO and NO are known sources of free radicals and can
inducethereductionofferritin(Fe3+)tofreeF e 2+,contribut-
ingtooxidativedamage[15,16];boththesecomponentsalso
play a very important role in the pathogenesis of IBD [17,
18].Moreover,MPOistheenzymeproducedmainlybyPMN
leukocytes and is associated with the degree of neutrophil
inﬁltration in given tissues. Hence, we evaluated the eﬀect of
anthocyanins extract on colonic NO production and MPO
activity. After 6 days of TNBS treatment, MPO activity of the
TNBS group markedly increased to a level ∼10 times higher
than that found in the vehicle group. The increase in the
MPOactivitywassigniﬁcantlyreducedbytheadministration
of anthocyanins extract, and in the group administered with
40mgkg−1 of anthocyanins extract, the MPO activity wasEvidence-Based Complementary and Alternative Medicine 7





































































































































Figure 8: (a–d) Eﬀects of anthocyanins extract on inﬂammatory cytokine production in mice with TNBS-induced colitis. All doses of
anthocyanins extract signiﬁcantly inhibited the production of IL-12 (a), IFN-γ (b) and TNF-α (c), as well as restored the product of IL-10
(d). ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 005 versus vehicle group.
suppressed almost to a basal level. As the MPO activity
is considered to be a fundamental biochemical maker of
neutrophil inﬁltration [19], this result suggests that antho-
cyanins extract exerted protective eﬀects on IBD by reducing
neutrophil inﬁltration into the colonic mucosa. In addition,
the production of NO, another important mediator, was also
down-regulated by the administration of diﬀerent doses of
anthocyaninsextract.Theseresultsimplythatsomepotential
antioxidant natural products might have some important
roles on IBD therapy.
Finally, TNBS-induced colitis in mice was much similar
toIBDonhuman,whichmainlyresultedfromTh1-mediated
inﬂammation, and hence, we preliminarily investigated
the regulation of anthocyanins extract on Th1-mediated
cytokines that were involved in IBD. The results showed that
anthocyanins extract from blueberries could signiﬁcantly
inhibit the increasing expression of IL-12, TNF-α and
IFN-γ,a sw e l la sd e c r e a s et h el e v e lo fI L - 1 0( Figure 9). In
the experimental treatment of IBD, evidence proved that the
use of antibody speciﬁc for TNF-α was highly eﬀective [20].
Similar eﬀect was also observed when using IL-12 and -10
antibodies [21–24]. Our experimental results showed that
anthocyanins extract from blueberries could signiﬁcantly
equilibrate the irregular expression of cytokines induced
by colitis, and hence, we believe that the application of
anthocyaninsextractfromblueberriescouldbeanalternative
to cytokines targeting therapy with lower cost and lesser side
eﬀect.
Thus, it can be concluded that intrarectal injection
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Figure9:Maineﬀectsoftheanthocyaninsextractontheinﬂamma-
tory intestinal process induced by TNBS in rats. Grey bold arrows
indicate the inhibition in the inﬂammatory process.
inﬂammation. Treatment of mice with anthocyanins extract
from blueberries signiﬁcantly attenuated TNBS-induced
inﬂammation of the murine colon. Our results suggest that
the protective eﬀect of anthocyanins extract may be linked to
the re-equilibration of the irregular expression of cytokines
induced by colitis. Therefore, we can presume that the high-
dose intake of anthocyanins extract from blueberries (or
blueberries) can have some beneﬁcial eﬀects on IBD.8 Evidence-Based Complementary and Alternative Medicine
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